Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial
| Autor: | Achebe, Maureen Okam, Hassab, Hoda MA, Al-Kindi, Salam, Brown, Clark, Telfer, Paul, Biemond, Bart J., Lipato, Thokozeni, Davis, Mark, Gray, Sarah, Gordeuk, Victor R. |
|---|---|
| Zdroj: | In Blood 2 November 2023 142 Supplement 1:2527-2527 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|